# Dermapharm Holding SE (DMPHF)

> Healthcare · DE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DMPHF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 591.69M | € 68.56M | € 56.26M | € 1.17B | € 535.91M |
| 2025 | € 1.18B | € 134.64M | € 188.06M | € 1.05B | € 694.12M |
| 2024 | € 1.23B | € 117.89M | € 169.02M | € 979.61M | € 604.42M |
| 2023 | € 1.21B | € 66.18M | € 185.27M | € 1.08B | € 539.21M |
| 2022 | € 1.12B | € 146.59M | € 272.47M | € 516.45M | € 531.59M |
| 2021 | € 1.12B | € 249.92M | € 225.57M | € 580.30M | € 497.32M |
| 2020 | € 993.65M | € 107.43M | € 113.03M | € 606.80M | € 321.97M |
| 2019 | € 874.85M | € 96.36M | € 67.62M | € 554.61M | € 278.65M |
| 2018 | € 724.05M | € 95.28M | € 168.43M | € 304.32M | € 252.45M |
| 2017 | € 599.83M | € 121.21M | € 15.44M | € 254.75M | € 73.69M |
| 2016 | € 163.01M | € 7.84M | € 31.67M | € 162.78M | € 56.92M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.18 |
| Liabilities / Eq | 3.18 |
| Current Ratio | 1.71 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 8.96 |
| Gross Debt / FCF | 7.42 |

## Other views

- [Metrics](https://sponda.capital/en/DMPHF.md)
- [Charts](https://sponda.capital/en/DMPHF/charts.md)
- [Compare](https://sponda.capital/en/DMPHF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.